Caris Life Sciences (CAI) EPS (Basic) (2024 - 2026)
Caris Life Sciences (CAI) posted quarterly EPS (Basic) of -$0.0 for Q1 2026, up 99.95% year-over-year from -$0.0 in Q1 2025, and down 100.37% quarter-over-quarter from $0.49 in Q4 2025.
Caris Life Sciences (CAI) EPS (Basic) (2024 - 2026) Analysis & Trends
Caris Life Sciences' EPS (Basic) history runs 3 years deep, the most recent figure standing at -$0.0 for Q1 2026.
- In Q1 2026, EPS (Basic) rose 99.95% year-over-year to -$0.0; the TTM figure through Mar 2026 stood at -$1.46 (up 86.03% YoY), while the FY2025 annual figure was -$3.22, up 69.81% from the prior year.
- EPS (Basic) for Q1 2026 stood at -$0.0, down from $0.49 in the prior quarter.
- The five-year high for EPS (Basic) was $0.49 in Q4 2025, with the low at -$7.97 in Q2 2025.
- The 3-year median for EPS (Basic) is -$2.14 (2024), against an average of -$2.23.
- Peak annual rise in EPS (Basic) reached 128.09% in 2025, while the deepest fall reached 213.88% in 2025.
- Caris Life Sciences' EPS (Basic) stood at -$1.75 in 2024, then soared by 128.09% to $0.49 in 2025, then sank by 100.37% to -$0.0 in 2026.
- Business Quant data shows CAI's EPS (Basic) at -$0.0 in Q1 2026, $0.49 in Q4 2025, and $0.09 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 7.59 |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -3.06 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.16 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 0.00 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.18 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.23 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.06 |
| 10 | Caris Life Sciences | 6.16 Bn | 5.37 Bn | 182.38 Mn | 0.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.00 |
| Mar 31, 2026 | 0.00 |
| Dec 31, 2025 | 0.49 |
| Sep 30, 2025 | 0.09 |
| Jun 30, 2025 | -7.97 |
| Mar 31, 2025 | -3.57 |
| Dec 31, 2024 | -1.75 |
| Sep 30, 2024 | -2.59 |
| Jun 30, 2024 | -2.54 |